Hepatitis B and HIV Co-infection
exp date isn't null, but text field is
- Hepatitis B virus (HBV) is the leading cause of chronic liver disease among HIV patients. In Uganda, the prevalence of Hepatitis B among HIV patients is estimated to be at 17%. (see Chronic Hepatitis B Infection for more details)
- All HIV-infected patients initiating and those failing ART should be routinely screened for HBV infection using Hep B surface Antigen (HBsAg)
- People living with HIV with a positive HBsAg should have other complementary tests at baseline and repeated every 6 months and these include:
- A complete blood count
- Liver function tests: ALT, AST, albumin, bilirubin, PT-INR
- Liver ultrasound scan: to assess stage of liver fibrosis
- Repeat tests every 6 months since patients with chronic HBV infection are at increased risk for hepatocellular carcinoma
Management of HBV/HIV co-infection
The goal of HBV/HIV treatment is to prevent dual disease progression and to reduce HBV-related morbidity and mortality.
Treatment
Preferably ART regimen containing:
- TDF 300 mg + 3TC 300 mg PO once daily for life
- After 6 months of treatment, patients should be evaluated for HBV treatment failure
If jaundice, malaise and abdominal right upper quadrant pain are present or if liver function tests are abnormal
- Do HBV DNA (hepatitis viral load) if any of the above is present
Treatment Failure
- Patients with HB VL >2000 IU/ml at 24 weeks of therapy should be referred for further evaluation and management
Prevention of HBV infection
- Counseling: emphasize sexual transmission as well as the risks associated with sharing needles and syringes, tattooing or body-piercing
- Advise patients with chronic HBV disease to avoid alcohol consumption
- All household members and sexual partners of people living with HIV with HBV should be screened for HBsAG
- HBV Vaccination is the most effective way to prevent HBV infection and its consequences
- All HIV-infected patients who test negative on HBsAg should be vaccinated with HBV vaccine
- All sexual partners and contacts should receive HBV vaccination regardless of whether they are HIV-infected or not